The Discounted Cash Flow (DCF) valuation of Charles River Laboratories International Inc (CRL) is 135.68 USD. With the latest stock price at 183.88 USD, the upside of Charles River Laboratories International Inc based on DCF is -26.2%.
Based on the latest price of 183.88 USD and our DCF valuation, Charles River Laboratories International Inc (CRL) is a sell. selling CRL stocks now will result in a potential gain of 26.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.8% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 71.58 - 391.85 | 135.68 |
| Upside | -61.1% - 113.1% | -26.2% |